Abdel-Aziz M - Search Results

1

STAT3 transcription factor as target for anti-cancer therapy.

Mohassab AM, Hassan HA, Abdelhamid D, Abdel-Aziz M. Mohassab AM, et al. Pharmacol Rep. 2020 Oct;72(5):1101-1124. doi: 10.1007/s43440-020-00156-5. Epub 2020 Sep 2. Pharmacol Rep. 2020. PMID: 32880101 Review.

2

1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain.

Hassan HA, Abdel-Aziz M, Abuo-Rahma Gel-D, Farag HH. Hassan HA, et al. Bioorg Med Chem. 2009 Feb 15;17(4):1681-92. doi: 10.1016/j.bmc.2008.12.051. Epub 2008 Dec 29. Bioorg Med Chem. 2009. PMID: 19147368

3

N-malonyl-1,2-dihydroisoquinoline as a novel carrier for specific delivery of drugs to the brain.

Abdel-Aziz M, Abuo-Rahma Gel-D, Hassan HA, Farag HH. Abdel-Aziz M, et al. Arch Pharm (Weinheim). 2010 Jan;343(1):54-60. doi: 10.1002/ardp.200900109. Arch Pharm (Weinheim). 2010. PMID: 19899103

4

Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.

Mohassab AM, Hassan HA, Abdelhamid D, Abdel-Aziz M, Dalby KN, Kaoud TS. Mohassab AM, et al. Bioorg Chem. 2017 Dec;75:242-259. doi: 10.1016/j.bioorg.2017.09.018. Epub 2017 Sep 30. Bioorg Chem. 2017. PMID: 29032325

5

New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells.

Ahmed FF, Abd El-Hafeez AA, Abbas SH, Abdelhamid D, Abdel-Aziz M. Ahmed FF, et al. Eur J Med Chem. 2018 May 10;151:705-722. doi: 10.1016/j.ejmech.2018.03.073. Epub 2018 Mar 27. Eur J Med Chem. 2018. PMID: 29660690

6

1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities.

Fathi MAA, Abd El-Hafeez AA, Abdelhamid D, Abbas SH, Montano MM, Abdel-Aziz M. Fathi MAA, et al. Bioorg Chem. 2019 Mar;84:150-163. doi: 10.1016/j.bioorg.2018.11.032. Epub 2018 Nov 22. Bioorg Chem. 2019. PMID: 30502626 Free PMC article.

7

NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.

Kaoud TS, Mohassab AM, Hassan HA, Yan C, Van Ravenstein SX, Abdelhamid D, Dalby KN, Abdel-Aziz M. Kaoud TS, et al. Eur J Med Chem. 2020 Jan 15;186:111885. doi: 10.1016/j.ejmech.2019.111885. Epub 2019 Nov 14. Eur J Med Chem. 2020. PMID: 31784187

8

Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF^V600E kinases.

Mohassab AM, Hassan HA, Abdelhamid D, Gouda AM, Youssif BGM, Tateishi H, Fujita M, Otsuka M, Abdel-Aziz M. Mohassab AM, et al. Bioorg Chem. 2021 Jan;106:104510. doi: 10.1016/j.bioorg.2020.104510. Epub 2020 Nov 24. Bioorg Chem. 2021. PMID: 33279248

9

JNK signaling as a target for anticancer therapy.

Abdelrahman KS, Hassan HA, Abdel-Aziz SA, Marzouk AA, Narumi A, Konno H, Abdel-Aziz M. Abdelrahman KS, et al. Pharmacol Rep. 2021 Apr;73(2):405-434. doi: 10.1007/s43440-021-00238-y. Epub 2021 Mar 12. Pharmacol Rep. 2021. PMID: 33710509 Review.

10

New 1,3,4-oxadiazole-chalcone/benzimidazole hybrids as potent antiproliferative agents.

Hagar FF, Abbas SH, Abdelhamid D, Gomaa HAM, Youssif BGM, Abdel-Aziz M. Hagar FF, et al. Arch Pharm (Weinheim). 2023 Feb;356(2):e2200357. doi: 10.1002/ardp.202200357. Epub 2022 Nov 9. Arch Pharm (Weinheim). 2023. PMID: 36351754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page